Drug Database
Back to search

Norway· NO-ID_FDA9E04E-6AF3-4E04-8E87-0A7C09F9498E

Sinalfa

A terazosin product containing terazosin, registered in Norway by Amdipharm Limited. The same ATC class is registered in 12 of our 19 countries.

ATC G04CA03

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedSinalfaATCG04CA03REGISTER NO.NO-ID_FDA9E04E-6AF3-4…PACKS LISTED3CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about terazosinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Terazosin is registered in 12 of 19 countries.

Countries holding a registration under ATC G04CA03 (terazosin), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 7 of them publish a price we can compare per daily dose
Search terazosin products by name

Terazosin · ATC G04CA03

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of terazosin costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.19 in United States to $0.93 in Switzerland — a ×5.0 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Terazosin · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.93
  • IT Italy$0.31
  • US United States$0.19 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Terazosin
Manufacturer
Amdipharm Limited
Country
Norway (NO)
ATC code
G04CA03
ATC class
Terazosin
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

1 priced
  • no_merkevare_id
    ID_FDA9E04E-6AF3-4E04-8E87-0A7C09F9498E
  • no_varenummer
    534727
    98
    NOK 232.2
  • gtin
    5060064170618

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

186 interactions on record for terazosin.

Graded by severity as the source publishes them — 72 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check terazosin against other medicinesHow interaction checks work

Terazosin · interactions on record

186 records

  • 72 moderate
  • 1 minor
  • 112 info

Most severe, free to view

  • ThiethylperazinA04AB03moderate
  • DiphenhydraminA04AB05moderate
  • DronabinolA04AD10moderate
  • NabiloneA04AD11moderate

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Terazosin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All terazosin products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Uroflo, Vicard
  • Belgium · Hytrin, Terazosab
  • Czechia · Kornam
  • Germany · Heitrin, Tera Tad
  • Denmark · Sinalfa
  • Spain · Alfaprost, Mayul
  • France · Dysalfa, Hytrine
  • United Kingdom (Northern Ireland) · Hytrin, Terazosin
  • Greece · Hytrin
  • Hungary · Setegis
  • Ireland · Hytrin
  • Italy · Itrin, Prostatil
  • Luxembourg · Hytrin, Terazosab
  • Netherlands · Hytrin, Terazosine Accord
  • Poland · Hytrin, Kornam
  • Portugal · Hytrin
  • Sweden · Sinalfa
  • Slovenia · Kornam
  • Slovakia · Kornam

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/33cb2c50-5e7e-42e7-ba10-cbb8017a67b5
GET /v1/drugs/33cb2c50-5e7e-42e7-ba10-cbb8017a67b5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett",
  "source": "fest",
  "status": "A",
  "atc_name": "Terazosin",
  "merkevare_id": "ID_FDA9E04E-6AF3-4E04-8E87-0A7C09F9498E",
  "name_form_strength": "Sinalfa tab 2 mg",
  "prescription_group": "C"
}
API referenceMCP serverPlans

See everything about terazosin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console